Scientists find the genetic switch that makes pancreatic cancer resist chemotherapy

Researchers at Duke-NUS Medical School have discovered a molecular “switch” that determines whether pancreatic cancer cells respond to chemotherapy or resist it. The finding points to a way to potentially shift some of the most treatment…

Continue Reading

News Source: www.sciencedaily.com